Researcher Profiles

Meet our incredible scientists! The men and women of LUNGevity’s science community are the top lung cancer researchers and clinicians in the country. They are also people like us who care deeply about reducing the mortality rates of lung cancer and have dedicated their professional lives to doing so.

Find out more by reading the profiles of these very special individuals. We’re all working together toward the same goal!

Dr. Jennifer BeaneDr. Jennifer Beane

Jennifer Beane, PhD, Assistant Professor of Computational Biomedicine at Boston University School of Medicine, was awarded a LUNGevity Career Development Award. Though she is still forging her career as a scientist, her exceptional research findings in the early detection of lung cancer have demonstrated her promise as a successful lung cancer researcher. Read more...

Dr. Jeffrey A. BorgiaDr. Jeffrey Borgia

Jeffrey A. Borgia, PhD, Assistant Professor of Biochemistry and Pathology, and several of his colleagues from Rush University Medical Center were awarded a research grant from LUNGevity Foundation to identify biomarkers and develop a noninvasive test for the early detection of lung cancer. Read more...

Timothy BurnsDr. Timothy Burns

Timothy Burns, MD, PhD, Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Pittsburgh Cancer Institute, was awarded a LUNGevity Career Development Award. His efforts to develop personalized treatments in lung cancer have demonstrated his promise as a successful lung cancer researcher. Read more...

Dr. Lauren ByersDr. Lauren Byers

Lauren Byers, MD, Assistant Professor of Thoracic and Head and Neck Medical Oncology at the University of Texas MD Anderson Cancer Center, was awarded a LUNGevity Career Development Award. Though she is still building her career as a scientist, her exceptional discovery of a potential new treatment for small cell lung cancer has demonstrated her promise as a lifelong lung cancer researcher. Read more...

Dr. CarboneDr. David Carbone

David Carbone, MD, PhD, Director of the Thoracic Oncology Center at The Ohio State University, and colleagues in the lung cancer field have been awarded a LUNGevity grant for innovative research to better match non-small cell lung cancer (NSCLC) patients with the most effective treatments. Read more...

Dr. Steve DubinetteDr. Steve Dubinett

Dr. Steve Dubinett is a creative scientist. He believes in looking hard at the scientific data and then pushes his thoughts away from conventional ideas. He likes to work collaboratively with others who are willing to forge new paths in research and it has paid off. Dr. Dubinett, Chief of Pulmonary and Critical Care Medicine at the University of California, Los Angeles, is best known for uncovering surprising connections between inflammation and lung cancer. Read more...

Edward GabrielsonDr. Edward Gabrielson

Edward Gabrielson, MD, Professor of Pathology and Oncology, and a colleague at Johns Hopkins Medicine have been awarded a research grant from LUNGevity Foundation to support their work identifying a biomarker for the development of targeted lung cancer therapies. Read more...

Halmos.jpgDr. Balazs Halmos

Balazs Halmos, MD, Associate Professor of Clinical Medicine at Columbia University Medical Center, and his colleagues have been awarded a research grant from LUNGevity Foundation to study ways to increase the effectiveness of radiation and chemotherapy in treating non-small cell lung cancer (NSCLC) that could potentially also lead to developing biomarkers for personalized NSCLC treatments. Read more...

Samir HanashDr. Samir Hanash

Samir Hanash, MD, PhD, Professor of Clinical Cancer Prevention at the University of Texas MD Anderson Cancer Center, was awarded a research grant by LUNGevity Foundation to develop a method for the early detection of lung cancer. Read more...

Dr. Mohamed HassaneinDr. Mohamed Hassanein

Mohamed Hassanein, PhD, Research Instructor in the Division of Allergy, Pulmonary, and Critical Care Medicine at the Vanderbilt University Medical Center, was awarded a LUNGevity Career Development Award in 2012. Though he is still forging his career as a scientist, he has made solid progress in his studies to develop an early detection test for lung cancer. Through his impactful work, Dr. Hassanein has demonstrated the ability to make progress in the field of lung cancer. Read more...

Dr. Rebecca HeistDr. Rebecca Heist

Rebecca Heist, MD, MPH, Assistant Professor of Medicine at Harvard Medical School and thoracic oncologist at Massachusetts General Hospital, and her colleagues were awarded a research grant from LUNGevity Foundation to identify biomarkers for the development of targeted lung cancer therapies. Read more...

Dr. John V. HeymachDr. John Heymach

John V. Heymach, MD, PhD, and colleagues were awarded a research grant from LUNGevity Foundation to develop better predictive biomarkers and treatment protocols for non-small cell lung cancer patients. Read more...

Feng JiangDr. Feng Jiang

Feng Jiang, MD, PhD, Associate Professor of Pathology, and his colleagues at the University of Maryland, Baltimore, have been awarded a research grant from LUNGevity Foundation to identify sputum biomarkers that could ultimately serve as the basis for the early detection of lung cancer. Read more...

David KozonoDr. David Kozono

David Kozono, MD, PhD, a radiation oncology specialist at the Dana-Farber Cancer Institute, was awarded a LUNGevity Career Development Award. Though he is still forging his career as a scientist, his efforts to improve lung cancer treatment have demonstrated his promise as a successful lung cancer researcher. Read more...

Dr. Christopher MaherDr. Christopher Maher

Christopher Maher, PhD, Assistant Professor of Internal Medicine at Washington University in St. Louis was awarded a LUNGevity Career Development Award in 2012. Though he is still forging his career as a scientist, he has already leveraged advanced sequencing technologies to identify important genetic changes in prostate and breast cancers. As he now turns his attention to the pulmonary system, he has the potential to make similar progress in lung cancer. Read more...

Dr. York E. MillerDr. York E. Miller

York E. Miller, MD, Professor of Medicine specializing in Pulmonary Sciences, and colleagues from the University of Colorado Denver were awarded a research grant from LUNGevity Foundation to develop better predictive biomarkers for lung cancer patients. Read more...

Dr. Suzanne MiyamotoDr. Suzanne Miyamoto

Suzanne Miyamoto, PhD, Associate Research Biochemist, and her colleagues at the University of California, Davis, have been awarded a research grant from LUNGevity Foundation to develop sensitive early detection methods for lung cancer patients. Read more...

Dr. Viswam NairDr. Viswam S. Nair

Viswam S. Nair, MS, MD, Instructor of Pulmonary and Critical Care Medicine at Stanford University, was awarded a LUNGevity Career Development Award in 2012. Though he is still forging his career as a scientist, Dr. Nair has spearheaded an effort to build a large database of pre-surgical lung cancer imaging scans with associated blood samples that are already being used by multiple research teams at Stanford. In addition to being an excellent physician, Dr. Nair has demonstrated his ability to harness his energy, creativity and scientific acumen to make progress in the field of lung cancer. Read more...

Dr. Edward PatzDr. Edward Patz

Edward F. Patz, Jr., MD, James and Alice Chen Professor of Radiology, Professor in Pathology, Professor in Pharmacology and Cancer Biology, and his colleagues from the Duke University Medical Center were awarded a research grant from LUNGevity Foundation to identify biomarkers for the early detection of lung cancer. Read more...

Lecia SequistDr. Lecia Sequist

Lecia V. Sequist, MD, MPH, Associate Professor at Massachusetts General Hospital and Harvard Medical School, has been awarded a research grant from LUNGevity Foundation to lay the groundwork for overcoming drug resistance when treating non-small cell lung cancer (NSCLC). Read more...

Frank SlackDr. Frank Slack

Frank Slack, PhD, Professor of Molecular, Cellular and Developmental Biology at Yale University, and his colleagues have been awarded a research grant from LUNGevity Foundation to continue studying inherited sections of DNA that could be used as biomarkers for lung cancer risk or as targets for personalized treatment. Read more...

Meredith TennisDr. Meredith Tennis

Meredith Tennis, PhD, a researcher in the Department of Pulmonary Science and Critical Care Medicine at the University of Colorado Denver, was awarded a LUNGevity Career Development Award. Her studies focusing on reducing lung cancer risk have demonstrated her promise as a successful lung cancer researcher. Read more...

Dr. Alexander Steven WhiteheadAlexander Steven Whitehead

Alexander Steven Whitehead, DPhil, Professor of Pharmacology, and his colleagues at the University of Pennsylvania were awarded a research grant from LUNGevity Foundation to identify biomarkers for the development of targeted lung cancer therapy. Read more...

Ignacio Wistuba for Sept 2013 e-newsletterIgnacio Wistuba

Ignacio Wistuba, MD, Chairman and Professor of Translational Molecular Pathology, and his colleagues at the University of Texas MD Anderson Cancer Center have been awarded a research grant from LUNGevity Foundation to identify biomarkers that can ultimately serve as the basis for the early detection of small cell lung cancer (SCLC). Read more...